ArticleTherapeutic advances in medical oncology2022

Single-course bleomycin, etoposide, and cisplatin (1xBEP) as adjuvant treatment in testicular nonseminoma clinical stage 1: outcome, safety, and risk factors for relapse in a population-based study.

Klaus-Peter Dieckmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.